Monday, November 14, 2016
- 9:00AM-11:00AM
-
Abstract Number: 1452
18 F-FDG PET Imaging: An In Vivo quantitative Drug Screening Tool for Novel Antiinflammatory Therapies
Rheumatoid Arthritis – Animal Models - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1540
“I Am Always in Pain Somewhere”: Continuing Unmet Need in Rheumatoid Arthritis
Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications- 9:00AM-11:00AM
-
Abstract Number: 1249
“There Are Still a Lot of Things That I Need”: A Qualitative Study Exploring Opportunities to Improve the Health Outcomes of First Nations People with Arthritis Seen at an on-Reserve Outreach Rheumatology Clinic
Healthcare Disparities in Rheumatology - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1145
#Rheumjc: Impact of Invited Authors on a Twitter Based Rheumatology Journal Club
Education - Poster- 9:00AM-11:00AM
-
Abstract Number: 1304
2D and 3D Measurements of Osteoarthritis Joint Space Width Have Good Agreement in Radiographically Normal Knees but Poor Agreement with Advancing Kellgren-Lawrence Grade: Data from the Osteoarthritis Initiative
Imaging of Rheumatic Diseases - Poster II: XR/CT/PET/MRI- 9:00AM-11:00AM
-
Abstract Number: 1557
3-D Explant Method Facilitates the Study of Lymphocytes in Synovium and Reveals a Population of Resident Memory-like T Cells in Rheumatoid Arthritis
Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1651
A Case Series on Patients on Tofacitinib in Combination with a Biologic
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1212
A Combined Large Scale Meta-Analysis Identifies COG6 As a Novel Shared Risk Locus for Rheumatoid Arthritis and Systemic Lupus Erythematosus
Genetics, Genomics and Proteomics - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1233
A Descriptive Analysis of Real-World Treatment Patterns of Innovator Infliximab (Remicade) and Biosimilar Infliximab in a Treatment NaïVe Turkish Rheumatologic Disease Population
Health Services Research - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1840
A Dichotomy of Regulatory Immunome Is Related to Disease Activity in Juvenile Systemic Lupus Erythematosus
Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster I- 9:00AM-11:00AM
-
Abstract Number: 1094
A Dual Role of Bromodomain Containing 1 Protein in Rheumatoid Arthritis Synovial Fibroblasts
Biology and Pathology of Bone and Joint - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1604
a First-in-Human Study of CR6086, a New Potent EP4 Prostanoid Receptor Antagonist, Demonstrates Good Safety and Tolerability at Therapeutically Relevant Exposures
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1375
A Five Year Study of 102 Children with Juvenile Myositis: Disease Course and Outcomes
Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster II: Myositis, Systemic Lupus Erythematosus, Sjögren's Syndrome- 9:00AM-11:00AM
-
Abstract Number: 1567
A Functional Genomic Screen of Rheumatoid Arthritis Risk Genes in Primary Human T Cells Reveals DDX6 As a Negative Modulator of Cytokine Expression